This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumura, N.
Right arrow Articles by Mitsuhashi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumura, N.
Right arrow Articles by Mitsuhashi, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 1998, p. 176-179, Vol. 42, No. 1
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Sequences of Homologous beta -Lactamases from Clinical Isolates of Serratia marcescens with Different Substrate Specificities

Naoki Matsumura,1,* Shinzaburo Minami,2 and Susumu Mitsuhashi1

Episome Institute, 2220 Kogure, Fujimi-mura, Seta-gun Gunma,1 and Research Laboratories, Toyama Chemical Co., Ltd., 2-4-1 Shimo-okui, Toyama-city, Toyama, 930,2 Japan

Received 12 March 1997/Returned for modification 22 July 1997/Accepted 22 October 1997

Genes for two group 1 beta -lactamases, SRT-1 and SST-1, were sequenced. These beta -lactamases were produced by clinical isolates of Serratia marcescens, isolates GN16694 and GN19450, respectively. The resulting enzymes were 96% identical. SRT-1 hydrolyzed oxyimino cephalosporins, but SST-1 hardly hydrolyzed them. At residue 213 in the third motif, which is conserved among group 1 beta -lactamases, SRT-1 and SST-1 had Lys and Glu, respectively. By site-directed mutagenesis, the substitution of Glu by Lys at residue 213 in SST-1 resulted in an enzyme that hydrolyzed oxyimino cephalosporins.


* Corresponding author. Mailing address: Research Laboratories, Toyama Chemical Co., Ltd., 2-4-1 Shimo-okui, Toyama-city, Toyama, 930 Japan. Phone: 81-764-31-8268. Fax: 81-764-31-8208.


Antimicrobial Agents and Chemotherapy, January 1998, p. 176-179, Vol. 42, No. 1
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rodriguez-Martinez, J.-M., Poirel, L., Nordmann, P. (2009). Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 1766-1771 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Papagiannitsis, C. C., Tzouvelekis, L. S., Tzelepi, E., Miriagou, V. (2007). Plasmid-Encoded ACC-4, an Extended-Spectrum Cephalosporinase Variant from Escherichia coli. Antimicrob. Agents Chemother. 51: 3763-3767 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Nordmann, P. (2007). Extension of the hydrolysis spectrum of AmpC {beta}-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J Antimicrob Chemother 60: 490-494 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Fortineau, N., Nordmann, P. (2006). Naturally Occurring Extended-Spectrum Cephalosporinases in Escherichia coli.. Antimicrob. Agents Chemother. 50: 2573-2576 [Abstract] [Full Text]  
  • Jacoby, G. A. (2006). {beta}-Lactamase Nomenclature.. Antimicrob. Agents Chemother. 50: 1123-1129 [Full Text]  
  • Lau, S. K. P., Ho, P.-l., Li, M. W. S., Tsoi, H.-w., Yung, R. W. H., Woo, P. C. Y., Yuen, K.-y. (2005). Cloning and Characterization of a Chromosomal Class C {beta}-Lactamase and Its Regulatory Gene in Laribacter hongkongensis. Antimicrob. Agents Chemother. 49: 1957-1964 [Abstract] [Full Text]  
  • Hidri, N., Barnaud, G., Decre, D., Cerceau, C., Lalande, V., Petit, J. C., Labia, R., Arlet, G. (2005). Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC {beta}-lactamase of a Serratia marcescens clinical isolate. J Antimicrob Chemother 55: 496-499 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Bemer, P., Drugeon, H., Nordmann, P. (2004). Resistance to Cefepime and Cefpirome Due to a 4-Amino-Acid Deletion in the Chromosome-Encoded AmpC {beta}-Lactamase of a Serratia marcescens Clinical Isolate. Antimicrob. Agents Chemother. 48: 716-720 [Abstract] [Full Text]  
  • Mahlen, S. D., Morrow, S. S., Abdalhamid, B., Hanson, N. D. (2003). Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. J Antimicrob Chemother 51: 791-802 [Abstract] [Full Text]  
  • Bonnet, R., Chanal, C., Ageron, E., Sirot, D., De Champs, C., Grimont, P., Sirot, J. (2002). Inducible AmpC {beta}-Lactamase of a New Member Enterobacteriaceae. Antimicrob. Agents Chemother. 46: 3316-3319 [Abstract] [Full Text]  
  • Nadjar, D., Labia, R., Cerceau, C., Bizet, C., Philippon, A., Arlet, G. (2001). Molecular Characterization of Chromosomal Class C {beta}-Lactamase and Its Regulatory Gene in Ochrobactrum anthropi. Antimicrob. Agents Chemother. 45: 2324-2330 [Abstract] [Full Text]  
  • Raimondi, A., Sisto, F., Nikaido, H. (2001). Mutation in Serratia marcescens AmpC {beta}-Lactamase Producing High-Level Resistance to Ceftazidime and Cefpirome. Antimicrob. Agents Chemother. 45: 2331-2339 [Abstract] [Full Text]  
  • Girlich, D., Naas, T., Bellais, S., Poirel, L., Karim, A., Nordmann, P. (2000). Heterogeneity of AmpC Cephalosporinases of Hafnia alvei Clinical Isolates Expressing Inducible or Constitutive Ceftazidime Resistance Phenotypes. Antimicrob. Agents Chemother. 44: 3220-3223 [Abstract] [Full Text]  
  • Girlich, D., Naas, T., Bellais, S., Poirel, L., Karim, A., Nordmann, P. (2000). Biochemical-Genetic Characterization and Regulation of Expression of an ACC-1-Like Chromosome-Borne Cephalosporinase from Hafnia alvei. Antimicrob. Agents Chemother. 44: 1470-1478 [Abstract] [Full Text]  
  • Poirel, L., Guibert, M., Girlich, D., Naas, T., Nordmann, P. (1999). Cloning, Sequence Analyses, Expression, and Distribution of ampC-ampR from Morganella morganii Clinical Isolates. Antimicrob. Agents Chemother. 43: 769-776 [Abstract] [Full Text]